[A Case of a Rupture of the Carotid Artery Caused by the Lenvatinib Medication]

Gan To Kagaku Ryoho. 2017 Nov;44(12):1610-1612.
[Article in Japanese]

Abstract

We report a case of a rupture of the common carotid artery caused by the medication of lenvatinib. The patient, 70-yearold female, was referred to our hospital by unresectable papillary thyroid cancer infiltrated the left common carotid artery. Externalbeam radiotherapy and radioiodine therapy were undergone after totalthyroidectomy. After 1 year 7 months from operation, she admitted our hospital due to left shoulder pain and dysphagia caused by the growing left cervical tumor. The medication of lenvatinib was decided after the careful informed consent. Computed tomography on the eighth day of lenvatinib medication showed the existence of air infiltration into the tumor surrounded left common carotid artery. So, a discontinuance of lenvatinib medication was decided immediately. But, on the ninth day, a rupture of the left common carotid artery occurred and on the tenth day, she died. Lenvatinib medication for the patient with the tumor surrounded artery should be decided carefully.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Carcinoma, Papillary / therapy*
  • Carotid Artery Diseases / chemically induced*
  • Carotid Artery Diseases / therapy
  • Fatal Outcome
  • Female
  • Humans
  • Phenylurea Compounds / adverse effects*
  • Phenylurea Compounds / therapeutic use
  • Quinolines / adverse effects*
  • Quinolines / therapeutic use
  • Rupture / chemically induced*
  • Rupture / therapy
  • Thyroid Cancer, Papillary
  • Thyroid Neoplasms / therapy*

Substances

  • Antineoplastic Agents
  • Phenylurea Compounds
  • Quinolines
  • lenvatinib